Cytogen, a precision medical company based on Circulation Tumor Cell , announced on the 5th tha.. - MK -
| 217330 Stock | KRW 6,180 640.00 9.38% |
About 62% of Cytogen's investor base is looking to short. The analysis of current outlook of investing in Cytogen suggests that many traders are alarmed regarding Cytogen's prospects. The current market sentiment, together with Cytogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Cytogen stock news signals to limit their universe of possible portfolio assets.
Cytogen |
Cytogen, a precision medical company based on Circulation Tumor Cell , announced on the 5th tha.. - MK
Read at news.google.com
 |
Cytogen Fundamental Analysis
We analyze Cytogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Cytogen is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Cytogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytogen stock to make a market-neutral strategy. Peer analysis of Cytogen could also be used in its relative valuation, which is a method of valuing Cytogen by comparing valuation metrics with similar companies.
Peers
Cytogen Related Equities
| 078150 | HB Technology | 0.77 | ||||
| 019540 | Ilji Technology | 0.66 | ||||
| 010280 | Ssangyong Information | 0.47 | ||||
| 153460 | Nable Communications | 0.62 | ||||
| 036630 | Sejong Telecom | 2.27 | ||||
| 500007 | Shinhan Inverse | 2.48 | ||||
| 058730 | Dong A | 5.76 |
Complementary Tools for Cytogen Stock analysis
When running Cytogen's price analysis, check to measure Cytogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytogen is operating at the current time. Most of Cytogen's value examination focuses on studying past and present price action to predict the probability of Cytogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytogen's price. Additionally, you may evaluate how the addition of Cytogen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |